CEACAM5 and colorectal carcinoma: Carcinoembryonic antigen (CEA) and CA19-9 have been commonly assessed in CRC patients, but with varying results depending on the study design and the study population [4], and their clinical association with cancer metastasis have not been demonstrated thus far.